Evidence map›Paper›PMID 32973807›Full record

ArticleFrontiers in immunology2020

Pioneering Study on

Caio B Abreu, Karla C F Bordon, Felipe A Cerni, Isadora S Oliveira, Carla Balenzuela, Gabriel M Alexandre-Silva, Karina F Zoccal, Mouzarllem B Reis, Gisele A Wiezel, Steve Peigneur and 8 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Antifungal activity ofToxicon: X · 2022
    Article
  9. Scorpion species of medical importance in the Brazilian Amazon: a review to identify knowledge gaps.The journal of venomous animals and toxins including tropical diseases · 2021
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 2 countries.

Caio B AbreuMedical School, Federal University of Roraima, Boa Vista, Brazil.
Karla C F BordonDepartment of BioMolecular Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, São Paulo, Brazil.
Felipe A CerniDepartment of BioMolecular Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, São Paulo, Brazil.
Isadora S OliveiraDepartment of BioMolecular Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, São Paulo, Brazil.
Carla BalenzuelaMedical School, Federal University of Roraima, Boa Vista, Brazil.
Gabriel M Alexandre-SilvaMedical School, Federal University of Roraima, Boa Vista, Brazil.
Karina F ZoccalBarão de Mauá University Center, Ribeirão Preto, Brazil.
Mouzarllem B ReisBarão de Mauá University Center, Ribeirão Preto, Brazil.
Gisele A WiezelDepartment of BioMolecular Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, São Paulo, Brazil.
Steve PeigneurToxicology and Pharmacology, KU Leuven, Leuven, Belgium.
Ernesto L Pinheiro-JúniorToxicology and Pharmacology, KU Leuven, Leuven, Belgium.
Jan TytgatToxicology and Pharmacology, KU Leuven, Leuven, Belgium.
Tiago M CunhaDepartment of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil.
Loic QuintonMass Spectrometry Laboratory, MolSys Research Unit, Liège Université, Liège, Belgium.
Lúcia H FaccioliDepartment of Clinical Analysis, Toxicology and Food Science, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, São Paulo, Brazil.
Eliane C ArantesDepartment of BioMolecular Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, São Paulo, Brazil.
Umberto ZottichMedical School, Federal University of Roraima, Boa Vista, Brazil.
Manuela B PuccaMedical School, Federal University of Roraima, Boa Vista, Brazil.
Universidade de São Paulo · BRUniversidade Federal de Roraima · BRKU Leuven · BECentro Universitário Barão de Mauá · BRUniversity of Liège · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Scorpionism is responsible for most accidents involving venomous animals in Brazil, which leads to severe symptoms that can evolve to death. Scorpion venoms consist of complexes cocktails, including peptides, proteins, and non-protein compounds, making separation and purification procedures extremely difficult and time-consuming. Scorpion toxins target different biological systems and can be used in basic science, for clinical, and biotechnological applications. This study is the first to explore the venom content of the unexplored scorpion species

Indexed as

AnimalsAntiveninsCell LineChromatography, LiquidCross ReactionsHumansHyaluronoglucosaminidaseInflammation MediatorsIon ChannelsMicePeptidesScorpionsScorpion StingsScorpion VenomsSequence Analysis, ProteinAntiveninsHyaluronoglucosaminidaseInflammation MediatorsIon ChannelsPeptidesScorpion Venomselectrophysiologyneurotoxinnociceptionpro-inflammatory toxinRhopalurus crassicaudascorpion venomtoxin

Identifiers

PMID32973807
PMCPMC7468477
OpenAlexW3081118773

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.